This largecap pharma stock surges 32% in two days; here’s why
In the past one month, the share price has gained nearly 57%, while it more than doubled against its 52-week low of ₹861.5 touched on May 22, 2023.
In the past one month, the share price has gained nearly 57%, while it more than doubled against its 52-week low of ₹861.5 touched on May 22, 2023.
The stock has fallen nearly 27% since May 18, 2023, after the pharma company released its fourth-quarter results